Mapping of the minimal domain encoding a conformational epitope by lambda phage surface display: factor VIII inhibitor antibodies from haemophilia A patients.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  JIM - Journal of Immunological Methods

• Publication date

  1999-04-22

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0022-1759(99)00012-5PMID 10357210
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Some human inhibitor antibodies interfere with factor VIII binding to factor IX.

  1998cited by this paper
• Efficient display of an HCV cDNA expression library as C-terminal fusion to the capsid protein D of bacteriophage lambda.

  1998cited by this paper
• The Canine Factor VIII cDNA and 5’ Flanking Sequence

  1998cited by this paper
• Epitope mapping and serodiagnosis using Ata- and (Lys)7 peptides.

  1998cited by this paper
• A human alloantibody interferes with binding of factor IXa to the factor VIII light chain.

  1998cited by this paper
• The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.

  1997cited by this paper
• Epitope mapping by phage display: random versus gene-fragment libraries.

  1997cited by this paper
• Efficient epitope mapping by bacteriophage lambda surface display.

  1997cited by this paper
• Analysis of the Human Factor VIII A2 Inhibitor Epitope by Alanine Scanning Mutagenesis*

  1997cited by this paper
• Epitope mapping by negative selection of randomized antigen libraries displayed on filamentous phage.

  1997cited by this paper
• The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor*

  1997cited by this paper
• Efficient epitope mapping by bacteriophage λ surface display

  1997cited by this paper
• Role of capsid structure and membrane protein processing in determining the size and copy number of peptides displayed on the major coat protein of filamentous bacteriophage.

  1996cited by this paper
• Surface Display of Proteins on Bacteriophage λ Heads

  1996cited by this paper
• Surface display of proteins on bacteriophage lambda heads.

  1996cited by this paper
• Tea bag synthesis of positional scanning synthetic combinatorial libraries and their use for mapping antigenic determinants.

  1996cited by this paper
• Interactions of protein antigens with antibodies.

  1996cited by this paper
• A Mechanism for Inhibition of Factor VIII Binding to Phospholipid by von Willebrand Factor (*)

  1995cited by this paper
• A model for transmembrane signalling by the aspartate receptor based on random-cassette mutagenesis and site-directed disulfide cross-linking.

  1995cited by this paper
• Common inhibitory effects of human anti‐C2 domain inhibitor alloantibodies on factor VIII binding to von Willebrand factor

  1995cited by this paper
• Use of a gene-targeted phage display random epitope library to map an antigenic determinant on the bluetongue virus outer capsid protein VP5.

  1995cited by this paper
• Identification of functional interaction sites on proteins using bacteriophage-displayed random epitope libraries.

  1995cited by this paper
• Display of peptides and proteins on the surface of bacteriophage lambda.

  1995cited by this paper
• Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site.

  1995cited by this paper
• NMR mapping of the antigenic determinant recognized by an anti-gp120, human immunodeficiency virus neutralizing antibody.

  1995cited by this paper
• Mapping of linear epitopes recognized by monoclonal antibodies with gene-fragment phage display libraries

  1995cited by this paper
• Locations of disulfide bonds and free cysteines in the heavy and light chains of recombinant human factor VIII (antihemophilic factor A)

  1995cited by this paper
• Assembly of functional bacteriophage lambda virions incorporating C-terminal peptide or protein fusions with the major tail protein.

  1995cited by this paper
• Residues 484-508 Contain a Major Determinant of the Inhibitory Epitope in the A2 Domain of Human Factor VIII (*)

  1995cited by this paper
• Identification of biologically active peptides using random libraries displayed on phage.

  1995cited by this paper
• Lambda foo: a lambda phage vector for the expression of foreign proteins.

  1994cited by this paper
• Mutagenic PCR.

  1994cited by this paper
• Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides.

  1993cited by this paper
• A Factor VIII Neutralizing Monoclonal Antibody and a Human Inhibitor Alloantibody Recognizing Epitopes in the C2 Domain Inhibit Factor VIII Binding to von Willebrand Factor and to Phosphatidylserine

  1993cited by this paper
• Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli.

  1993cited by this paper
• Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs.

  1992cited by this paper
• Characterization of a factor VIII immunogenic site using factor VIII synthetic peptide 1687-1695 and rabbit anti-peptide antibodies.

  1992cited by this paper
• Epitope mapping of human factor VIII inhibitor antibodies by site‐directed mutagenesis of a factor VIII polypeptide

  1992cited by this paper
• A Soluble Recombinant Factor VIII Fragment Containing the A2 Domain Binds to Some Human Anti-Factor VIII Antibodies that Are not Detected by Immunoblotting

  1992cited by this paper
• High resolution functional analysis of antibody-antigen interactions.

  1992cited by this paper
• Light-directed, spatially addressable parallel chemical synthesis.

  1991cited by this paper
• Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit.

  1991cited by this paper
• Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine.

  1990cited by this paper
• Searching for peptide ligands with an epitope library.

  1990cited by this paper
• An antibody binding site on cytochrome c defined by hydrogen exchange and two-dimensional NMR.

  1990cited by this paper
• Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization.

  1989cited by this paper
• Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid.

  1989cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting.

  1987cited by this paper
• Strategies for epitope analysis using peptide synthesis.

  1987cited by this paper
• Efficient mapping of protein antigenic determinants.

  1986cited by this paper
• Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution

  1986cited by this paper
• Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

  1985cited by this paper
• Molecular cloning of a cDNA encoding human antihaemophilic factor

  1984cited by this paper
• Expression of active human factor VIII from recombinant DNA clones

  1984cited by this paper
• Structure of human factor VIII

  1984cited by this paper
• The role of phospholipid and factor VIIIa in the activation of bovine factor X.

  1981cited by this paper
• Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

  1971cited by this paper

• Phage Display Broadly Identifies Inhibitor-reactive Regions in von Willebrand Factor

  2021cites this paper
• Tumor-Targeting Peptides: The Functional Screen of Glioblastoma Homing Peptides to the Target Protein FABP3 (MDGI)

  2020cites this paper
• Isolation of Novel Autoantigens by Lambda Phage Surface Display

  2018influential citation
• Six Amino Acid Residues in a 1200 Å2 Interface Mediate Binding of Factor VIII to an IgG4κ Inhibitory Antibody

  2015cites this paper
• identification of an inhibitory antibody epitope on the surface of factor VIII Fab complex: κ immunoglobulin G4 - Structure of a factor VIII C2 domain

  2013cites this paper
• Simultaneous display of two large proteins on the head and tail of bacteriophage lambda

  2013cites this paper
• Synthesis of water-soluble scaffolds for peptide cyclization, labeling, and ligation.

  2012cites this paper
• Surface Analysis of Adsorbed Proteins: A Multi-Technique Approach to Characterize Surface Structure

  2012cites this paper
• Identification of ADAMTS13 peptide sequences binding to von Willebrand factor.

  2010cites this paper
• Dual expression system for assembling phage lambda display particle (LDP) vaccine to porcine Circovirus 2 (PCV2).

  2010cites this paper
• Functional reconstruction of structurally complex epitopes using CLIPS™ technology

  2009cites this paper
• B-Cell and T-Cell Epitopes in Anti-factor VIII Immune Responses

  2009cites this paper
• What a polyclonal antibody sees in von Willebrand factor.

  2008cites this paper
• Construction of a Positive Selection Marker by a Lethal Gene with the Amber Stop Codon(s) Regulator

  2006cites this paper
• Characterization of Factor VIII Inhibitors

  2006cites this paper
• Display libraries on bacteriophage lambda capsid.

  2005cites this paper
• Phage Display: a Molecular Fashion Show

  2005cites this paper
• Epitope mapping using mRNA display and a unidirectional nested deletion library.

  2005cites this paper
• Peptide modulators of G protein signaling

  2005cites this paper
• High-density functional display of proteins on bacteriophage lambda.

  2003cites this paper
• Changes in Epitope Specificity and in Distribution of IgG Subtypes of FVIII Antibodies during Immune Tolerance Therapy (ITT) in Hemophilia A Patients with FVIII Antibodies — a Case Report

  2002cites this paper
• Four Hydrophobic Amino Acids of the Factor VIII C2 Domain Are Constituents of Both the Membrane-binding and von Willebrand Factor-binding Motifs*

  2002cites this paper
• Affinity selection of DNA-binding proteins from yeast genomic DNA libraries by improved lambda phage display vector.

  2002cites this paper
• Characterization of antibodies to coagulation factor VIII

  2002cites this paper
• Epitope Mapping of Neutralizing Botulinum Neurotoxin A Antibodies by Phage Display

  2001cites this paper
• Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII.

  2001cites this paper
• Protein-protein interactions in hematology and phage display.

  2001cites this paper
• Epitope mapping of factor VIII inhibitor antibodies of Chinese origin

  2001cites this paper
• Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure.

  2000cites this paper
• Affinity selection of cDNA libraries by lambda phage surface display.

  2000cites this paper
• Affinity selection of cDNA libraries by λ phage surface display

  2000cites this paper
• Structure of the C2 domain of human factor VIII at 1.5 Å resolution

  1999cites this paper
• Epitope Mapping by Phage Display

  1998cites this paper